Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.1 (
protein kinase
)
81,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The family of testis-specific serine-threonine kinases (TSSKs) consists of four members whose expression is confined almost exclusively to testis. Very little is known about their physiological role and mechanisms of action. We cloned human and mouse
TSSK3
and analysed the biochemical properties, substrate specificity and in vitro activation. In vitro
TSSK3
exhibited the ability to autophosphorylate and to phosphorylate test substrates such as histones, myelin basic protein and casein. Interestingly,
TSSK3
showed maximal in vitro kinase activity at 30 degrees C, in keeping with it being testis specific. Sequence comparison indicated the existence of a so-called 'T-loop' within the
TSSK3
catalytic domain, a structure present in the AGC family of protein kinases. To test if this T-loop is engaged in
TSSK3
regulation, we mutated the critical threonine residue within the T-loop to alanine (T168A) which resulted in inactivation of
TSSK3
kinase. Furthermore, Thr168 is phosphorylated in vitro by the T-loop kinase phosphoinositide-dependent
protein kinase
-1 (PDK1). PDK1-induced phosphorylation increased in vitro
TSSK3
kinase activity, suggesting that
TSSK3
can be regulated in the same way as AGC kinase family members. Analysis of peptide sequences identifies the peptide sequence RRSSSY containing Ser5 that is a target for
TSSK3
phosphorylation, as an efficient and specific substrate for
TSSK3
.
...
PMID:Characterization of testis-specific serine-threonine kinase 3 and its activation by phosphoinositide-dependent kinase-1-dependent signalling. 1633 68